Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)-论文-万方医学网

首页> > Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)

Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)

导出原文传递

翻译打印收藏纠错

第一作者： Welty, M.

作者： Welty, M. ; Mesana, L. ; Padhiar, A. ; Naessens, D. ; Diels, J. ; van Sanden, S. ; Pacou, M.

发布时间 2022-10-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)

相似文献

同项目论文

相关期刊

检索历史 清除

Efficacy of ustekinumab versus advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis (vol 36, pg 595, 2020)

相似文献

同项目论文

相关期刊

检索历史清除